Professor David Huang, 2018 Clunies Ross Knowledge Commercialisation Awardee, and collaborators Associate Professor Peter Czabotar and Associate Professor Guillaume Lessene talk about their role in the development of a novel, potent anti-cancer drug called venetoclax.
Read the transcript of this podcast.